Mirae Asset Global Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$111K Buy
8,032
+613
+8% +$9.77K ﹤0.01% 1163
2025
Q4
$120K Buy
7,419
+1,532
+26% +$25K ﹤0.01% 1228
2025
Q3
$88.1K Buy
5,887
+18
+0.3% +$219 ﹤0.01% 1240
2025
Q2
$68.4K Buy
5,869
+931
+19% +$8.46K ﹤0.01% 1208
2025
Q1
$37.9K Buy
4,938
+20
+0.4% +$154 ﹤0.01% 1293
2024
Q4
$30.9K Sell
4,918
-416
-8% -$2.29K ﹤0.01% 1350
2024
Q3
$26.7K Buy
5,334
+934
+21% +$4.07K ﹤0.01% 1394
2024
Q2
$15.2K Sell
4,400
-46,079
-91% -$146K ﹤0.01% 1422
2024
Q1
$394K Sell
50,479
-3,932
-7% -$15.2K ﹤0.01% 2004
2023
Q4
$267K Buy
54,411
+217
+0.4% +$990 ﹤0.01% 2242
2023
Q3
$295K Sell
54,194
-1,100
-2% -$7.27K ﹤0.01% 2135
2023
Q2
$371K Sell
55,294
-1,208
-2% -$8.98K ﹤0.01% 2083
2023
Q1
$499K Sell
56,502
-2,033
-3% -$17.9K ﹤0.01% 1924
2022
Q4
$447K Buy
58,535
+1,706
+3% +$13.3K ﹤0.01% 1952
2022
Q3
$404K Buy
56,829
+16,500
+41% +$155K ﹤0.01% 2003
2022
Q2
$326K Buy
+40,329
New +$355K ﹤0.01% 1946
2019
Q4
Sell
-167,600
Closed -$5.18M 1470
2019
Q3
$5.18M Buy
+167,600
New +$6.84M 0.04% 455

Other funds holding ADPT

Mirae Asset Global Investments's ADPT Position: Q1 2026 in Review

Mirae Asset Global Investments increased its Adaptive Biotechnologies (ADPT) stake by 8.3% in Q1 2026, buying an estimated $9.77K and bringing the position to 8,032 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.

Mirae Asset Global Investments first reported a position in ADPT in Q3 2019 and has held it in 17 quarters since. The position peaked at $5.18M in Q3 2019. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Mirae Asset Global Investments held 8,032 shares of Adaptive Biotechnologies worth $111K as of Q1 2026.
  • Mirae Asset Global Investments bought 613 Adaptive Biotechnologies shares in Q1 2026, an estimated $9.77K.
  • Adaptive Biotechnologies made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q1 2026, its #1163 holding.
  • Mirae Asset Global Investments first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Adaptive Biotechnologies position peaked at $5.18M in Q3 2019.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.